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ipates in transcriptional regulation, as a component of are investigating whether or not this mechanism operates
in cycling mammalian cells in culture. In S. pombe, ge-transcription factor TFIIH. A physiological role for CDK7
in activating CDKs and promoting cell cycle progression netic studies by Beach et al identified a nonessential
kinase, Csk1, that seemed to stimulate the kinase associ-has now been firmly established by studies of a CDK7
homologue in Drosophila. In budding yeast, CAK activ- ated with Mcs2, the fission yeast homologue of cyclin H.
We therefore constructed baculoviruses to overexpressity is supplied by a distinct single-subunit protein kinase,
Cak1, whereas Kin28, the closest homologue of CDK7, Mcs6 (the CDK7 homologue), Mcs2, and Csk1 (the po-
tential CAKAK) for biochemical studies in vitro. Re-functions solely in transcription. A CAK in the fission
yeast, Schizosaccharomyces pombe, the Mcs6-Mcs2 com- markably, Csk1 is indeed a potent CAKAK in vitro. We
have also combined temperature-sensitive mutations inplex, closely resembles the metazoan enzyme and so
presents a novel opportunity to study CDK activation mcs6 and mcs2 with a Dcsk1 null mutation; the resulting
growth retardation (or arrest in the presence of an addi-in a genetically tractable organism. We are investigating
the regulatory pathways upstream of CAK by a combina- tional mutation, cdc2-3W) suggests more severe compro-
mise of CDK activation when both functions are defec-tion of biochemical and genetic strategies in both mam-
malian cells and fission yeast. tive. We are also investigating how MAT1 influences the
activity of the trimeric CAK complex. We have estab-The two major forms of CDK7 in mammalian cells—
the dimer and the trimer—may be assembled by distinct lished stable mammalian cell lines that conditionally ex-
press MAT1 in both wild-type and various mutant forms.molecular mechanisms. A stable association between
CDK7 and cyclin H in a binary complex requires phosphor- This will allow us to search for novel protein targets of
MAT1 that would be candidate substrates for CDK7.ylation of CDK7 by a CAK-activating kinase (CAKAK),
whereas ternary complex assembly and activation can Finally, we are comparing the substrate specificities and
other enzymatic properties of pure dimeric and trimericoccur in the absence of phosphorylation through the
action of MAT1. Thus, to understand the mechanisms CAK generated in insect cells using baculoviruses, with
several known substrates that may be important for cellcontrolling CAK function, we are pursuing two major
lines of investigation: the identification and characteriza- cycle control, transcription, or other processes.
tion of CAKAKS, both in vitro and in vivo, and a system-
atic search for proteins that interact with MAT1, either REFERENCES
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Events in the budding yeast cell cycle are driven by through the cell cycle such that peak abundance of the
regulators corresponds closely with their natural timecyclical accumulation and destruction of cyclin-depen-
of function. There are at least three major points ofdent kinase (CDK) activators (cyclins) and inhibitors.
transcriptional control: in postmitotic prereplicativeTranscription of most of these regulators is controlled
cells, in cells committed to cell cycle initiation, and in
cells that have completed DNA replication and are pre-
paring for mitosis. At all three points, positive feedback1 Speaker and participant
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Entry into the S phase in budding yeast requires inacti- ize the localization, abundance, and composition of SCF
complexes in vivo. Homologues of SCF components havevation of the S-phase cyclin-dependent kinase (CDK)
inhibitor Sic1. We have shown that this is achieved via been detected in other eukaryotes, and a human Cdc53
homologue (CUL1) is able to complement a cdc53tsphosphorylation-triggered ubiquitin-dependent proteoly-
sis. During the early G1 phase, stable Sic1 prevents the mutant. Human CUL1, SKP1, and SKP2 (an F-box pro-
tein that is presumed to serve as a Cdc4-like substrateprecocious activation of S-phase–promoting CDK com-
plexes. Late in the G1 phase, newly assembled G1 cyclin/ receptor) assemble into SCF-like complexes upon ex-
pression in insect cells, but these complexes have notCDK complexes phosphorylate Sic1 (G1 cyclin/CDK
complexes are insensitive to Sic1 inhibition). Phospho- yet been shown to catalyze CDC34-dependent ubiquiti-
nation of a defined substrate. However, human CUL1Sic1 is selectively recognized by a ubiquitin ligase (E3)
complex containing Cdc53, Cdc4, and Skp1. This assem- and human SKP1 can assemble into chimeric SCF com-
plexes with yeast Cdc4, and these complexes can sustainblage has been named SCF for Skp1-Cdc53/CUL-F Box
receptor E3 complex. Upon binding to SCF, phospho- the Cdc34-dependent ubiquitination of phospho-Sic1,
confirming that the yeast and human proteins possessSic1 is extensively ubiquitinated by the Cdc34 ubiquitin-
conjugating enzyme. Coprecipitation analyses have re- similar biochemical functions. We have recently devel-
oped a biochemical assay that may allow us to identifyvealed that the Cdc4 and Skp1 subunits of SCF selectively
bind phospho-Sic1, thereby linking it to Cdc53 and substrates and/or regulators of human CUL1 complexes.
The identification of CUL1 as a component of a ubiquitinCdc34. Efforts are currently underway to further subdi-
vide the functional organization of SCF and to character- ligase complex and the availability of biochemical assays
